The purpose of these cooperative agreements is to further Indian Health Service (IHS) health program objectives in the American Indian/Alaska Native (AI/AN) community with awareness, visibility, advocacy, and education efforts for the Behavioral Health (BH) and HIV/AIDS programs on a national scale and in the interest of improving Indian health care. This announcement includes two separate awards, each of which will be awarded as noted below. The purpose of the BH award is to promote behavioral health as central to the health and well-being of AI/AN communities.
The American Foundation for AIDS Research (AmFAR) announces the availability of support to community-based and other agencies for the development of prevention / education programs for those at risk due to IV drug use directly or through sexual contact with IV drug users. Areas which may be addressed are safer sex for IV drug users, safer needle use, and/or women of childbearing age whose partners are IV drug users.
The Centers for Disease Control and Prevention announces the availability of fiscal year 2016 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement High-Impact Human Immunodeficiency Virus (HIV) Prevention Programs in the following two categories: Category A: HIV prevention services for high risk Young Men of Color Who Have Sex with Men and their partners regardless of age, gender, and race/ethnicity.
The purpose of this Funding Opportunity Announcement (FOA) is to invite basic research project grant applications for HIV Microbiome Centers to perform investigations on the role of HIV-induced dysbiosis and how this imbalance may induce and/or contribute to the occurrence of heart, lung, or blood (HLB) co-morbidities in HIV positive individuals. This FOA will support mechanistic studies that will use in vitro, in vivo, ex vivo, and in silico models applied to HIV research.
For this 2016 funding round, as in previous years, the Elton John AIDS Foundation (EJAF) invites letters of intent (LOIs) from any proposed project that is working with people who are most affected by HIV in the Americas, defined as the United States, Canada, Mexico, the Caribbean, or Central or South America.
This Funding Opportunity Announcement (FOA) encourages Exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses.
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV infection: men who have sex with men (MSM), transgender women, and black/African American women. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to enroll and follow sufficient numbers of high-risk HIV-negative participants to reach seroconversion milestone targets.
The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.